Accès ouvert
2026
article
OpenAlex
Karl Hein, Laura Weydandt, Massimiliano Lia, Şenol Doğan et autres
INTRODUCTION: Seroma is the most common postoperative complication following mastectomy and may result in additional postoperative interventions and increased treatment burden. However, its etiology and predictive factors remain insufficiently understood. This study aimed to identify predictors of postoperative seroma formation. MATERIALS AND …
de
(code pays fourni par la source)
Accès ouvert
2026
other
OpenAlex
Karl Hein, Laura Weydandt, Massimiliano Lia, Şenol Doğan et autres
Abstract Introduction Seroma is the most common postoperative complication following mastectomy and may result in additional postoperative interventions and increased treatment burden. However, its etiology and predictive factors remain insufficiently understood. This study aimed to identify predictors of postoperative seroma formation. Materials …
de
(code pays fourni par la source)
Accès ouvert
2026
other
OpenAlex
Karl Hein, Laura Weydandt, Massimiliano Lia, Şenol Doğan et autres
Abstract Introduction Seroma is the most common postoperative complication following mastectomy and may result in additional postoperative interventions and increased treatment burden. However, its etiology and predictive factors remain insufficiently understood. This study aimed to identify predictors of postoperative seroma formation. Materials …
de
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Karl Hein, Laura Weydandt, Massimiliano Lia, Şenol Doğan et autres
Supplementary Material 1.
de
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Karl Hein, Laura Weydandt, Massimiliano Lia, Şenol Doğan et autres
Supplementary Material 1.
de
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Elisa Brochwitz, Ivonne Nel, Änne Eckardt, Laura Weydandt et autres
Despite effective primary treatment, approximately 20% of cervical cancer patients experience recurrence, which may be driven by early hematogenous dissemination. While circulating (CTCs) and disseminated tumor cells (DTCs) are established prognostic markers in breast cancer, their role in cervical cancer remains poorly …
de
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Ivonne Nel, Ekaterina Firsova, Laura Weydandt, B. Aktas
Abstract Background: Circulating cell-free DNA (cfDNA) profiling from blood plasma has demonstrated considerable potential for clinical applications in breast cancer, yet urinary cfDNA remains less explored. In a previous pilot study of plasma-derived and matching urinary cfDNA (n=30), we have found plasma …
de
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Laura Weydandt, K. Hein, Susanne Briest, Ivonne Nel et autres
Abstract Purpose: Seroma is the most common postoperative complication following mastectomy, often prolonging hospital stays and increasing the need for additional treatment. Despite its high prevalence, the etiology and predictive factors remain unclear. Therefore, identifying reliable predictors and potential causes remains a …
de
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Volkmar Müller, Henry J. Huebner, Patrick Ziegler, Sabrina Uhrig et autres
Abstract Background: CDK4/6 inhibitors in combination with endocrine therapy have become the standard first-line treatment for patients with hormone receptor-positive, HER2-negative (HR+/HER2-) advanced breast cancer. While ribociclib is supported by the most robust overall survival data across multiple phase III trials, mechanisms …
de, us, in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Laura Weydandt, Jana Jeschke, Anne Kathrin Höhn, Susanne Briest et autres
de
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Änne Eckardt, Laura Weydandt, Anne-Kathrin Höhn, Bahriye Aktas et autres
Abstract Background: Despite successful treatment of the primary tumor, recurrence occurs in about 30% of breast cancer patients. One possible reason might be micro-metastases, so-called disseminated tumor cells (DTC) in the bone marrow (BM), which split off from the primary tumor in …
2025
conference-abstract
OpenAlex
Susanne Briest, Laura Weydandt, Mireille Martin, Anne Kathrin Höhn et autres
Abstract Background: Breast-conserving therapy is a long-standing standard surgical procedure for treating breast cancer. The aim is the complete resection of the tumor with free margins to avoid additional surgery and possible relapse. The optimal way to document tumor-free margins intraoperatively is …